- Title
- HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL
- Creators
- M. Shadman - Fred Hutch Cancer CenterC. Yeung - Fred Hutch Cancer CenterM. Redman - Fred Hutch Cancer CenterS. Y. Lee - Fred Hutch Cancer CenterD. H. Lee - Fred Hutch Cancer CenterD. H. Qian - Fred Hutch Cancer CenterS. Ra - Fred Hutch Cancer CenterC. S. Ujjani - Fred Hutch Cancer CenterB. J. Dezube - BIOE. H. Warren - University of WashingtonA. G. Chapuis - Fred Hutch Cancer CenterD. J. Green - Fred Hutch Cancer CenterA. J. Cowan - Fred Hutch Cancer CenterR. D. Cassaday - Fred Hutch Cancer CenterH. Kiem - Fred Hutch Cancer CenterC. Poh - Fred Hutch Cancer CenterS. D. Smith - Fred Hutch Cancer CenterF. Milano - Fred Hutch Cancer CenterJ. Gauthier - Fred Hutch Cancer CenterA. V. Hirayama - Fred Hutch Cancer CenterC. J. Turtle - Fred Hutch Cancer CenterR. C. Lynch - Fred Hutch Cancer CenterA. K. Gopal - Fred Hutch Cancer CenterD. G. Maloney - Fred Hutch Cancer CenterB. G. Till - Fred Hutch Cancer Center
- Publication Details
- Hematological oncology, Vol.41(S2), pp.87-88
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032007860302976
Journal article
HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL
Hematological oncology, Vol.41(S2), pp.87-88
2023-06
Metrics
1 Record Views